Cargando…
Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease
INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative pathology that develops mainly in elderly and senile people. Disruption of BDNF transport or suppression of its production appears to be typical for people of old age. OBJECTIVES: Objective: To investigate the influence of Alzheimer’s dis...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471910/ http://dx.doi.org/10.1192/j.eurpsy.2021.371 |
_version_ | 1784789188196958208 |
---|---|
author | Sidenkova, A. |
author_facet | Sidenkova, A. |
author_sort | Sidenkova, A. |
collection | PubMed |
description | INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative pathology that develops mainly in elderly and senile people. Disruption of BDNF transport or suppression of its production appears to be typical for people of old age. OBJECTIVES: Objective: To investigate the influence of Alzheimer’s disease on the secretion of brain factors and correlate with neuropsychological profiles. METHODS: 12 men (2) and women (10) with Alzheimer’s disease were examined. The average age of the subjects was 76.25 + 4.89. Methods: MMSE, ADAS-COG, laboratory - BDNF was performed using the G7611 BDNF Emax (R) ImmunoAssaySystem 5 x 96 wells, BDNF Emax® Immunological test. RESULTS: 2 patients have mild dementia, 8 patients have moderate dementia, 2 patients have severe dementia. The average age of patients with mild dementia was 72.0 + 1.0. The average MMSE score is 16.7 + 3.4. Correlation analysis showed a close relationship between a pronounced decrease in memory in memory tests (ADAS-COG) and a pronounced decrease in blood BDNF content (r = 0.676). A close statistically significant relationship was found between a low result of the recognition test and a low blood BDNF content (r = 0.598). CONCLUSIONS: we assume that blood BDNF is a marker of pathologically accelerated aging of the central nervous system, since low test results for mnestic function are an indicator of severe degeneration in Alzheimer’s disease DISCLOSURE: No significant relationships. |
format | Online Article Text |
id | pubmed-9471910 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-94719102022-09-29 Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease Sidenkova, A. Eur Psychiatry Abstract INTRODUCTION: Alzheimer’s disease (AD) is a neurodegenerative pathology that develops mainly in elderly and senile people. Disruption of BDNF transport or suppression of its production appears to be typical for people of old age. OBJECTIVES: Objective: To investigate the influence of Alzheimer’s disease on the secretion of brain factors and correlate with neuropsychological profiles. METHODS: 12 men (2) and women (10) with Alzheimer’s disease were examined. The average age of the subjects was 76.25 + 4.89. Methods: MMSE, ADAS-COG, laboratory - BDNF was performed using the G7611 BDNF Emax (R) ImmunoAssaySystem 5 x 96 wells, BDNF Emax® Immunological test. RESULTS: 2 patients have mild dementia, 8 patients have moderate dementia, 2 patients have severe dementia. The average age of patients with mild dementia was 72.0 + 1.0. The average MMSE score is 16.7 + 3.4. Correlation analysis showed a close relationship between a pronounced decrease in memory in memory tests (ADAS-COG) and a pronounced decrease in blood BDNF content (r = 0.676). A close statistically significant relationship was found between a low result of the recognition test and a low blood BDNF content (r = 0.598). CONCLUSIONS: we assume that blood BDNF is a marker of pathologically accelerated aging of the central nervous system, since low test results for mnestic function are an indicator of severe degeneration in Alzheimer’s disease DISCLOSURE: No significant relationships. Cambridge University Press 2021-08-13 /pmc/articles/PMC9471910/ http://dx.doi.org/10.1192/j.eurpsy.2021.371 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Abstract Sidenkova, A. Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease |
title | Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease |
title_full | Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease |
title_fullStr | Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease |
title_full_unstemmed | Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease |
title_short | Correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease |
title_sort | correlation of neurotrophic and neuropsychological parameters in alzheimer’s disease |
topic | Abstract |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9471910/ http://dx.doi.org/10.1192/j.eurpsy.2021.371 |
work_keys_str_mv | AT sidenkovaa correlationofneurotrophicandneuropsychologicalparametersinalzheimersdisease |